Consumer Health

The preference for herbal/traditional products has grown over the review period, driven by the demand for natural and 'clean' ingredients. This trend is evident in Slovenia across consumer healthcare, including paediatric consumer health, where…

Despite the tough economic landscape in South Africa and the cost of living crisis in the country consumers continue to purchase paediatric consumer health products. During the review period, consumers cut down on discretionary spending and were even…

Paediatric vitamins and dietary supplements remains by far the largest value category within paediatric consumer health. Despite a decline in retail volume sales in 2023, heightened health awareness since the pandemic and parents’ approach to…

Spain’s birth rate continues to fall, thereby reducing the target audience of paediatric consumer health and compounding declining growth rates in 2023. As there are no national policies to support a rise in the country’s birth rate, this trend is…

Paediatric consumer health remains a minor part of total consumer health in Sweden. The key reasons for this low share include the fact that children are usually treated with general products (suitable for adults and children) with the appropriate…

Value sales of paediatric consumer health remains positive in 2023. Swiss parents prefer to consult with their health practitioner when it comes to their children, and seek help from professionals before resorting to medical recommendations that lead…

Paediatric consumer health remains underdeveloped in Taiwan, with just two categories – paediatric vitamins and dietary supplements and paediatric cough/cold remedies – registering measurable sales during the review period. This is mainly because…

Paediatric vitamins and dietary supplements remained the largest and most dynamic product area in current value terms in 2023, with parents remaining keen to protect their children’s health. As demand grew, so too did the variety of offerings, with…

A significant decrease in the birth rate (per ‘000 population) in 2022 is expected to be followed by a marginal drop over 2023. The demand for assisted reproduction increased by around 15% in 2022, compared to the previous year. However, since this…

Over 2023, paediatric consumer health retail current value sales are expected to continue to grow healthily. On the other hand, retail volume development is projected to be marginal-to-moderate, with declines anticipated for paediatric acetaminophen…

The high sales growth being seen in paediatric consumer health in the Philippines is largely due to the country’s relatively high birth rate and the culture of not skimping when it comes to spending money on children. However, it should be noted that…

In the United Arab Emirates, there is wide knowledge of consumer health, due to the diverse make-up of the population. However, there are a significant number of parents who continue to be hesitant to give children over-the-counter medications due to…

Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…

It is evident that the average consumer has become more health-conscious since COVID-19, as seen through transformations in ingredient-focused product development in dermatologicals, alongside the rise of natural remedies and botanical compositions…

Paediatric vitamins and dietary supplements in Tunisia is experiencing remarkable growth in current value terms in 2023. This growth can be attributed to several factors, including the significant presence of both locally produced and imported…

In general, paediatric consumer health recorded strong retail volume growth during the early-to-mid-review period, with the outbreak of Coronavirus (COVID-19) in 2020 providing a particular fillip to demand. However, as the pandemic threat eased, the…

Value sales for paediatric consumer health continues to be low in Uruguay and in 2023 it is expected to register a slight decrease in constant value sales, as continuing rising prices cuts into profitability. Analgesics continues to account for most…

Uzbek parents are keen to prioritise the wellbeing of their children and have a strong propensity to invest in their health. This trend has been gathering pace over the review period especially during the challenging times of the COVID-19 pandemic…

Demand for paediatric consumer health remains strong and rising in 2023, driven by increasing attention to children’s overall health and wellbeing, and consistent consumer education in Vietnam. An increasing mindset of prevention is prompting some…

During 2023, sleep aids continued to benefit from the post- pandemic landscape of ongoing global economic instability, compounded by rampant inflation, which placed pressure on both middle- and low-income groups. As a result, consumers were forced to…

Australian consumers have become increasingly aware of the need for high-quality sleep to improve their overall health. With sleep experts recommending over seven hours of sleep for adults for the best result, consumers are searching for ways to not…

Retail volume sales of sleep aids are declining for the second year running in 2023. The outbreak of COVID-19 led to increased levels of fear and anxiety in 2020 and 2021 which helped drive record sales of sleep aids. With conditions improving in…

Sales of sleep aids are seeing more stable growth in 2023 after the peaks achieved in 2020-2021 when the pandemic created widespread anxiety and insomnia. Many people had to work from home and home-school their children during times of lockdown and…

Sleep aids is set to maintain dynamic retail volume growth and even stronger current value growth in Brazil in 2023. For many people, especially those in busy cities, getting a full eight hours sleep each night can feel like a luxury. The fast pace…

The demands of busy and stressful lifestyles in Bulgaria have given rise to a significant increase in the demand for sleep aids. As modern life becomes increasingly fast-paced and work-related pressures intensify, many individuals find themselves…

Sleep aids is projected to post fast retail volume growth over 2023. The category saw spikes in demand in 2020 and 2021 as the stress and anxiety of the Coronavirus (COVID-19) pandemic increased the incidence of sleep disorders or complaints. While…

Demand for sleep aids is growing in 2023 to remain significantly above pre-pandemic levels. Although value growth can also be considered healthy, it falls short when compared to the remarkable figures observed in 2021, when the category experienced…

Sleep disorders were already in the spotlight after the outbreak of COVID-19, and demand for sleep aids rose, given the disruption to daily routines, coupled with long screen hours during the lockdowns. However, despite the easing of COVID-19…

Sleep disorders have increased in Colombia since the pandemic due to the increased incidence of mental health issues and anxiety, whether diagnosed or not. The country still faces barriers to timely attention and diagnosis of psychological and…

Sleep aids is expected to register moderate current value growth and a slight increase in volume sales in 2023. The war in Ukraine and the resulting energy crisis are pushing up average retail prices. While Danes are now much less concerned about the…

Sleeping pills are in high demand in Egypt, leading to double-digit retail value growth in 2023. Sleep problems are very common in the country, with many people struggling to fall asleep or stay asleep, impacting their daily lives. Sleeping pills can…

Sleep aids sales are set to see continued growth in 2023. The major disruptions to lifestyles and the increasing economic pressures experienced in the last few years have led to a significant increase in the incidence of stress and anxiety and…

Demand for sleep aids remains high in 2023. Since the pandemic, an increase in sleep issues due to anxiety, depression, and stress, has spread among a large proportion of the French population. According to Euromonitor International’s Voice of the…

As in 2022, sleep aids was registering a slight decline in current value terms as a result of falling in 2023. While prices were still rising during the pandemic (2020, 2021), which, paired with increased volume demand for sleep aids during the…

The key growth driver in sleep aids in terms of ingredients is melatonin. The variety and availability of products based on melatonin increased dramatically at the end of the review period. The launch of Procter & Gamble’s ZzzQuil Nature made a…

The importance of mental health continues to command attention, with sleep being recognised as a crucial factor for maintaining overall wellbeing. The demand for products that address mental health concerns has surged in Hong Kong prompting…

While sleep aids is poised to record strong growth in current value sales in 2023, this is mainly due to price hikes amidst high inflation fuelled by the global recovery from COVID-19 and the fallout of Russia’s invasion of Ukraine. With inflationary…

In 2023, sleep aids is set to maintain positive retail volume and current value growth. Different ages have different needs when it comes to sleep; for example, younger children need around 10 hours of sleep, teenagers eight hours, adults six hours,…

General anxiety related to economic uncertainty, the high cost of living and the war in Ukraine is improving the popularity of sleep aids in 2023. Many consumers are also back to hectic everyday lifestyles, with commuting, longer working hours and a…

Demand for sleep aids remains strong in 2023, with everyday lifestyle issues and security concerns leading to sleep issues. The COVID-19 pandemic had a very strong impact on sleep in Israel and caused a surge in sleep deprivation and insomnia, which…

Sales of sleep aids continue to decline in 2023 in current value and retail volume terms, following the trend observed in the previous year. Sales of sleep aids soared in 2020 and 2021 following the outbreak of COVID-19 with the pandemic resulting in…

The potential market for sleep aids is expanding in Japan off the back of an increasing number of consumers facing poor sleep quality and fewer hours of sleep. This drop in quality sleep is due in part to a rise in telecommuting and prolonged use of…

In 2022, sleep aids experienced double-digit value growth, and this trend is continuing into 2023, with even more impressive retail volume growth as well. The catalyst for this growth is undoubtedly the lingering effects of the pandemic, which…

Sleep aids has shown another solid performance in 2023, with volume and current value growth rates set to surpass those recorded in 2022. Demand been buoyed by the easing of the pandemic, in that Moroccans have become more likely to experience…

Retail sales of sleep aids registered accelerated growth in current value terms in 2023, continuing the upward trajectory seen over the review period. Many New Zealanders struggled to achieve the recommended seven to eight hours sleep each night, and…

Sleep aids continued to register positive growth in volume sales in 2023 as the stress that increasing numbers of local consumers now face in their lives continued to take its toll on the nation’s sleep patterns. High stress levels are primarily the…

Sleep aids is a winner in consumer health in 2023, thanks to growing consumer awareness around such products and their benefits. This also stems from the era of the COVID-19 pandemic, which triggered both health and wellness trends and instances of…

A high proportion of Polish population suffer from sleep disorders, and this problem intensified during the review period. During the COVID-19 pandemic, consumers were forced to deal with high levels of anxiety and stress, which resulted in many…

Sleep aids has continued to register dynamic retail volume and current value growth in Portugal in 2023, continuing the positive trend established over the review period. Prior to the emergence the C19 pandemic, sleep disorders had been increasing…

A study has found that 16% of the Romanian population experience chronic insomnia, while 30% regularly struggle with insomnia. These percentages indicate a significant portion of the population affected by sleep-related issues and this high…